Solid Biosciences Inc. — Director's Dealing 2022

May 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-05-02

Reporting Person: Brennan Erin Powers (Chief Legal Officer, Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-02	Employee Stock Option (Right to Buy)	$0.55	A	254000	Acquired	2032-05-02	Common Stock (254000)	Direct

Footnotes

F1: This option was granted on May 2, 2022 and vests in three equal annual installments beginning on the first anniversary of the grant date.